NCT05070091 The Impact of Pituitary-thyroid and Pituitary-adrenal Axes Function on COVID-19 Clinical Course. Status COMPLETED Phase N/A
NCT05069636 Lymphatic Osteopathic Manipulative Medicine to Enhance Coronavirus (COVID-19) Vaccination Efficacy Status WITHDRAWN Phase NA
NCT05069623 A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers Status COMPLETED Phase PHASE1/PHASE2
NCT05069610 Evaluating Safety, Tolerability, and Potential Efficacy of Intranasal AD17002 in Adults With Mild to Moderate COVID-19 Status COMPLETED Phase PHASE1/PHASE2
NCT05069090 Effect of COVID-19 Lockdown on Alcohol and Tobacco Use in Two Chilean Universities Status COMPLETED Phase N/A
NCT05062525 Immune Response to COVID-19 Vaccine in Immunotherapy (IO) and Non-IO Treated Cancer Patients Status COMPLETED Phase N/A
NCT05060991 Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05059080 A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study Status TERMINATED Phase N/A
NCT05058742 Non-invasive Nervus Vagus Stimulation in Patients With COVID-19 and ARDS Status UNKNOWN Phase NA
NCT05058716 Assessment of Clinical Effects of Coenzyme Q10 Levels in COVID-19 Patients in Intensive Care Unit Status UNKNOWN Phase N/A
NCT05057260 LOng COvid Multidisciplinary Consortium: Optimising Treatments and servIces Across the NHS (LOCOMOTION) Status UNKNOWN Phase N/A
NCT05054621 Immunogenicity of COVID-19 Vaccine on Heterologous Schedule Status COMPLETED Phase PHASE2
NCT05054075 Protocol Design for Evaluating the Immunity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19 Status UNKNOWN Phase PHASE2
NCT05049200 Characteristics of Weaning From Mechanical Ventilation in COVID-19 Status COMPLETED Phase N/A
NCT05047601 A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Status COMPLETED Phase PHASE2/PHASE3
NCT05047445 A First Time in Human Phase 1 Open-Label Study of the COVIDITY Vaccine Administered by Needle-free Injection Status UNKNOWN Phase PHASE1